Oncology Pharma Inc. (ONPH)
OTCMKTS · Delayed Price · Currency is USD
0.0000
-0.0001 (-99.00%)
At close: Jul 30, 2025
Oncology Pharma Company Description
Oncology Pharma Inc., an oncology company, develops, manufactures, and commercializes therapeutics.
The company has a collaboration and licensing agreement with Kalos Therapeutics Inc. for exploring treatment opportunities of the COVID-19 virus.
The company was formerly known as SourcingLink.net Inc. and changed its name to Oncology Pharma Inc. in June 2019.
Oncology Pharma Inc. was incorporated in 1993 and is based in San Francisco, California.
Oncology Pharma Inc.
| Country | United States |
| Founded | 1993 |
| Industry | Biotechnology |
| Sector | Healthcare |
| Employees | 1 |
| CEO | George Malesek |
Contact Details
Address: 1 Sansome Street San Francisco, Delaware 94104 United States | |
| Phone | 415-869-1036 |
| Website | oncology-pharma.com |
Stock Details
| Ticker Symbol | ONPH |
| Exchange | OTCMKTS |
| Stock Type | Common Stock |
| Fiscal Year | April - March |
| Reporting Currency | USD |
| ISIN Number | US68235J2015 |
| SIC Code | 2836 |
Key Executives
| Name | Position |
|---|---|
| George Malesek | Interim Chief Executive Officer |
| Chuck Wagner | President, Treasurer and Chairman |
| Dimitri Theofilopolous Esq. | Legal Counsel |